Category Archives: News

Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing

Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing

Aurora Cannabis Inc. (“Aurora” or the “Company”) has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12,000,000 units of the Company (the “Units”), at a price of US$10.45 per Unit for gross proceeds of approximately US$125 million (the “Offering”). Each Unit will be comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant will be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

The Company has granted the Underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 10% of the Offering to cover over-allotments, if any. This option may be exercised by the Underwriters for additional Units, Common Shares, Warrants or any combination of such securities.

The net proceeds of the offering will be used for general corporate purposes, which may include opportunistically reducing debt. The Company believes that the Offering fits with its broader strategy to have a strong balance sheet while maintaining maximum flexibility to invest and build towards being a leader in global cannabinoids.

The closing of the Offering is expected to take place on or about January 26, 2021 and will be subject to customary conditions, including approvals of the Toronto Stock Exchange and the New York Stock Exchange.

A prospectus supplement (the “Prospectus Supplement”) to the Company’s short form base shelf prospectus dated October 28, 2020 (the “Base Shelf Prospectus”) will be filed with the securities commissions or securities regulatory authorities in each of the provinces of Canada, except Quebec, and with the U.S. Securities and Exchange Commission (the “SEC”) as part of the Company’s registration statement on Form F-10 (the “Registration Statement”) under the U.S./Canada Multijurisdictional Disclosure System. The Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement contain important detailed information about the Company and the proposed Offering. Prospective investors should read the Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement and the other documents the Company has filed for more complete information about the Company and this Offering before making an investment decision.

Copies of the Prospectus Supplement, following filing thereof, and the Base Shelf Prospectus will be available on SEDAR at www.sedar.com and copies of the Prospectus Supplement and the Registration Statement will be available on EDGAR at www.sec.gov . Copies of the Prospectus Supplement, following filing thereof, the Base Shelf Prospectus and the Registration Statement may also be obtained from BMO Capital Markets by contacting BMO Capital Markets, Brampton Distribution Centre C/O The Data Group of Companies, 9195 Torbram Road, Brampton, Ontario, L6S 6H2 or by telephone at (905) 791-3151 Ext 431 or by email at torbramwarehouse@datagroup.ca or from BMO Capital Markets Corp., Attn: Equity Syndicate Department, 3 Times Square, 25th Floor, New York, NY 10036 (Attn: Equity Syndicate), or by telephone at (800) 414-3627 or by email atbmoprospectus@bmo.com . Copies of such documents may also be obtained from ATB Capital Markets Inc., Attn: Gail O’Connor, 410-585 8th Ave SW, Calgary, Alberta, T2P 1G1, (403) 539-8629 or by email from atbcm_dealflow@atb.com .

No securities regulatory authority has either approved or disapproved of the contents of this press release. This press release is for information purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Aurora

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ‘71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more information, please visit our website at www.auroramj.com .

Aurora’s common shares trade on the TSX and NYSE under the symbol “ACB”, and is a constituent of the S&P/TSX Composite Index.

Further Information

For Media:For Investors:
Michelle LeflerICR, Inc.
VP, Communications & PRInvestor Relations
media@auroramj.comaurora@icrinc.com

Forward Looking Statements

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements “). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements made in this news release include statements regarding: the timing and completion of the Offering and the expected use of proceeds of the Offering. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward looking statements are based on the opinions, estimates and assumptions of management in light of management’s experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the ability to maintain SG&A costs in line with current expectations, the ability to achieve high margin revenues in the Canadian consumer market, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including the risks associated with: entering the U.S. market, the ability to realize the anticipated benefits associated with the acquisition of Reliva, achievement of Aurora’s business transformation plan, general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual information form dated September 24, 2020 (the “ AIF ”) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC’s website at www.edgar.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.


Primary Logo

Published at Thu, 21 Jan 2021 21:25:55 +0000

Data Shows Thats Cannabis Edibles Brands In The U.S. Are BOOMIN

Data Shows Thats Cannabis Edibles Brands In The U.S. Are BOOMIN

Last week, we came across an article that was published by MJ Biz Daily that covered the performance of the cannabis sector in 2020.

One of the most interesting statistics from the report is related the amount of edibles that were sold in 2020 and this is a trend that our readers should be aware of. Companies that are levered to the vertical have worked to modify the business to capitalize on the increased demand for edibles and we will monitor how these operators are able to execute

The increase in demand for edible product have accelerated the pace at which edibles manufacturers are investing in research and development (R&D) as well as new product lines. We expect 2021 to be a banner year for the edible market as consumers started to show a preference for smokeless cannabis products in 2020.

The acceleration in R&D on cannabis edibles has forced leading manufacturers to work on the development of faster-acting and strain-specific edibles. We believe the amount of time it takes to feel the effects of edibles has improved and expect brands to benefit from the development of these types of products.

Data Highlights the Increasing Demand for Edibles

According to Seattle-based cannabis analytics firm Headset, demand for medical and recreational cannabis edibles increased by 60% across seven state markets to $1.23 billion from $767 million in 2019.

According to Headset data analyst Cooper Ashley, market share for edibles increased to 11.07% in 2020 from 10.65%. We find these data points to be significant and expect the vertical to report stronger growth in 2021.

Headset also provided interesting data on the Michigan cannabis market and this is an opportunity that we have been closely following. Last year, the state’s recreational cannabis market opened, and we are impressed with the performance of it. According to Headset, Michigan recorded a 14% increase in sales of edible products. The firm said that edibles’ market share in Michigan increased from 14.4% to 16.5% and this is trend to be aware of.

Some of the key data points that Headset provided on the Michigan market include:

  1. Vape pens lost market share (from 24% to 20.1%)
  2. Flower increased market share (from 41.1% to 46.4%)
  3. Concentrates lost market share (from 9.6% to 7.7%)

During the last year, Michigan was one of the highly talked about cannabis markets and we expect the state to report strong growth this year. At the country level, we expect to see a similar trend play out as it relates to the mix of products that are being sold.

The US Cannabis Market is Accelerating Rapidly

Following the election of Joe Biden as President of the US and the democrats gaining control of the House of Representatives and the Senate, the cannabis industry is positioned to be a beneficiary of the changing of the guard.

Since the election, the cannabis sector has been in rally mode and we are seeing much smarter money enter the industry. Based on the outcome of the election, banks are starting to notice that the US cannabis market is the most attractive place to invest. While Canada is currently dominating in the international cannabis market, the US industry is expected to be the world’s largest cannabis market in the years to come.

We continue to prefer operators that are levered to states like Illinois or Michigan due to the limited number of licenses that are available. States like Florida, New York and Pennsylvania, are also limiting the number of cannabis licenses that are being granted and this plays a key role in our bullish outlook on these markets.

One of the reasons we are favorable on the cannabis edible market is related to the economics that are associated with it. To manufacture edibles, companies use cannabis extracts as the input product. Since these products are made with cannabis oil, the quality of the flower that is used to make the edibles does not come into question. We are of the opinion that this aspect of the process makes the cannabis edible vertical even more attractive from a margin appreciation standpoint and are favorable on the growth prospects that are associated with it.

If you are interested in learnings more about the companies that are capitalizing on the cannabis edible market, please send an email to support@technical420.com with the subject “Cannabis Edibles” to be added to our distribution list.

Share

Share - Facebook


Share - Twitter

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Fri, 22 Jan 2021 11:30:07 +0000

High Tide Opens New Canna Cabana Store in Calgary

High Tide Opens New Canna Cabana Store in Calgary

High Tide Inc. (TSXV: HITI) (OTCQB: HITIF) (FRA: 2LY), an Alberta -based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today announced that the Canna Cabana retail store located in Unit #101 624 8 Avenue SE, in Calgary’s Centre City East Village has begun selling recreational cannabis products for adult use. This will be the first retail cannabis store to begin servicing the local neighbourhood. This opening represents High Tide’s ninth Calgary location and 69th across Canada selling recreational cannabis products and consumption accessories.

ccstore 21 01 05 (CNW Group/High Tide Inc.)

“We continue to execute our retail expansion strategy by adding a great location in Calgary’s East Village,” said Raj Grover, President and Chief Executive Officer of High Tide. “The new store will follow High Tide’s well established and differentiated business model that offers consumers a one-stop shopping experience for all of their cannabis flower, beverage, edible and consumption accessory needs,” added Mr. Grover.

About High Tide Inc.

High Tide is a retail-focused cannabis company enhanced by the manufacturing and distribution of consumption accessories. The Company is the largest Canadian retailer of recreational cannabis as measured by revenue, with 69 current locations spanning Ontario , Alberta , Manitoba andSaskatchewan . High Tide’s retail segment features the Canna Cabana, KushBar, Meta Cannabis Co., Meta Cannabis Supply Co. and NewLeaf Cannabis banners, with additional locations under development across the country. High Tide has been serving consumers for over a decade through its numerous consumption accessory businesses including e-commerce platforms Grasscity.com and CBDcity.com, and its wholesale distribution division under Valiant Distribution, including the licensed entertainment product manufacturer Famous Brandz. High Tide’s strategy as a parent company is to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value. Key industry investors in High Tide include Aphria Inc. (TSX:APHA) (NYSE:APHA) and Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB).

Neither the TSX Venture Exchange (the “TSXV”) nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release are based on certain assumptions made by High Tide. While High Tide considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Readers are cautioned not to place undue reliance on forward-looking statements.

Forward-looking statements also necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving the retail cannabis markets; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the retail cannabis industries generally; income tax and regulatory matters; the ability of High Tide to implement its business strategy; competition; currency and interest rate fluctuations; the COVID-19 pandemic nationally and globally and the response of governments to the COVID-19 pandemic in respect of the operation of retail stores and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof, and thus are subject to change thereafter. High Tide disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Factors that could cause anticipated opportunities and actual results to differ materially include, but are not limited to, matters referred to above and elsewhere in High Tide’s public filings and material change reports, which are and will be available on SEDAR.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States of America . The securities have not been and will not be registered under the United States Securities Act of 1933 (the “1933 Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons (as defined in the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration is available .

SOURCE High Tide Inc.

 

Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2021/22/c7235.html

Published at Fri, 22 Jan 2021 12:11:59 +0000

Are These Marijuana Stocks Going To See More Momentum In 2021

Are These Marijuana Stocks Going To See More Momentum In 2021




Are These Marijuana Stocks Going To See More Momentum In 2021 | Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™
























Published at Fri, 22 Jan 2021 19:15:49 +0000

Unifor and Aleafia Health enter exclusive agreement to support medical cannabis coverage for members

Unifor and Aleafia Health enter exclusive agreement to support medical cannabis coverage for members

Unifor and Aleafia Health Inc. (TSX: AH, OTC: ALEAF), have entered into an exclusive 10-year agreement to support union members, retirees and their eligible dependents who receive medical cannabis insurance coverage through Unifor’s collective bargaining agreements.

“Unifor members across the country deserve access to the benefits of medical cannabis coverage through their benefits. As a union we will support our local bargaining committees to add this coverage where possible,” said Jerry Dias, Unifor National President.

The agreement supports a historic breakthrough in access to legal cannabis in Canada.

Aleafia brings unique national scale, organization and expertise to provide union members, retirees and their eligible dependents with access to medical cannabis product insurance reimbursement and physician-led cannabinoid therapy.

“This agreement will provide thousands of union members and their families with improved and affordable access to medical cannabis care, and ultimately be one of the largest breakthroughs in patient access since the early days of legalization in Canada,” said Geoffrey Benic, Aleafia Health CEO. “Our dedicated team of medical professionals and program managers are excited to begin working directly with Unifor members and launching this program.”

Through its subsidiaries, Aleafia Health provides an enhanced level of service not available through any other Canadian cannabis company. Members will receive a customized wellness regime, including cannabis education, virtual physician consultation, medical authorization, when appropriate, product ordering and scheduled home delivery, all in one business day.

  • Physician Expertise: Aleafia Health is a pioneer in cannabinoid therapy in Canada, providing care to over 75,000 unique patients. This has also provided actionable data on best practices on dosing, modes of intake, strain selection and patient safety, resulting in peer reviewed research published in medical journals. Best in class electronic medical records systems also allow close collaboration between Canabo physicians and Unifor members’ family doctor.
  • Virtual Consultation: Canabo today serves patients in every province of Canada. Since the beginning of Covid-19, the Company has transitioned to completing 100 per cent of consultations online and over the phone, allowing patients to receive professional care from the safety and convenience of their homes.
  • Product Portfolio:  Through its flagship medical cannabis brand Emblem, members will benefit from access to a diverse portfolio of high-quality cannabis formats, including oils, capsules, sprays, sublingual strips, vapes and exclusive dried flower cultivars. In addition, the Company looks forward to releasing a new line of CBD wellness products, which includes formats not yet available in Canada.
  • Scheduled Same Day Delivery: Through its AssureHome Delivery platform, Unifor members can order and will receive their medical cannabis order that evening, with best in class delivery times.

As Canada’s largest private sector union, Unifor represents over 315,000 members across every sector of the Canadian economy. Aleafia Health, a global cannabis health and wellness company, has provided over 75,000 individual patients with cannabinoid therapy through its national network of clinics, along with access to high-quality, federally regulated medical cannabis products.

About Unifor: https://www.unifor.org/en/about-unifor

Unifor is Canada’s largest union in the private sector, representing 315,000 workers in every major area of the economy. The union advocates for all working people and their rights, fights for equality and social justice in Canada and abroad, and strives to create progressive change for a better future.

About Aleafia Health:  www.AleafiaHealth.com

For media inquiries or to arrange interviews via FaceTime, Zoom or Skype with Dias or Benic please contact:
Hamid Osman, Unifor Communications Representative
647-448-2823 (cell) hamid.osman@unifor.org

Nicholas Bergamini, VP Investor Relations
1-833-879-2533 IR@AleafiaHealth.com

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns three significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Innovation, the heart of Aleafia Health’s competitive advantage, has led to the Company maintaining a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy. The Company is committed to creating sustainable shareholder value; the TSX Venture Exchange named Aleafia the 2019 top performing company prior to its graduation to the TSX.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Share

Share - Facebook


Share - Twitter

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Thu, 21 Jan 2021 13:33:07 +0000

American Cannabis Company, Inc. Announces Execution of Non-Binding Letter of Intent for Strategic Acquisition of a 60,000-sq.-ft. Cannabis Cultivation and Extraction Operation in Denver, Colorado

American Cannabis Company, Inc. Announces Execution of Non-Binding Letter of Intent for Strategic Acquisition of a 60,000-sq.-ft. Cannabis Cultivation and Extraction Operation in Denver, Colorado

American Cannabis Company, Inc. (OTCQB: AMMJ) is pleased to announce that it has successfully executed a non-binding letter of intent (LOI) with Andina Gold Corporation (OTCQB: AGOL) to purchase assets of its Good Meds and BOSM Labs operating division, a fully licensed cultivation and extraction operation in Colorado offering premium cannabis and cannabis extracts to the wholesale and retail medical and recreational markets. Assets are to include one cultivation operation and one hydrocarbon extraction laboratory and production center. All assets to be acquired will operate out of a 60,000-square-foot facility, centrally located in Denver, Colorado. Currently, only 50,000 square feet of space are being utilized, with 10,000 square feet of additional open space ready and available for the Company to use as it looks to scale up operations.

Since 2009, the Good Meds brand has cultivated and provided top-tier cannabis flower products to medical patients and recreational consumers in Colorado. BOSM Labs carries a strong reputation as a high-end manufacturer of well-known hydrocarbon-extracted cannabis products. Combined under one roof, these brands act as one of few long-standing and major contenders in the maturing Denver market.

Christopher Hansen, Chief Executive Officer of Andina Gold Corporation, commented: “We are pleased with the non-binding letter of intent with American Cannabis Company, and look forward to working with Terry Buffalo and his team to complete the transaction. The dedicated, consistently excellent work of Good Meds and BOSM Labs personnel has been the driver of their excellent reputation. We also appreciate the steady leadership through this transitional period provided by Amanda Price and John Haugh. We feel confident the impressive work of Good Meds and BOSM Labs will continue as we hand over the keys to American Cannabis Company.”

Terry Buffalo, Chief Executive Officer and Chief Financial Officer of American Cannabis Company, commented, “This is another strategic move for ACC. Officially having secured two non-binding LOIs to date, ACC will soon integrate three retail dispensaries and a total of 70,000 square feet of combined cultivation and extraction operations. The due diligence process for Good Meds and BOSM Labs has begun, and we anticipate this to close in Q2 of 2021. We analyzed many opportunities both here in Colorado as well as in other states, and we ultimately chose to focus on the Colorado market initially. This approach will allow us to improve existing operational processes, refine our workflow and deploy an operational management platform that we can use as we branch out to other regions of the country.”

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the company by promoting our operational management services and license the American Cannabis Company brand as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the High Times S.T.A.S.H. Award for “Best Potting Mix,” The Cultivation Cube™ and the High-Density Cultivation System™. American Cannabis Company also designs and provides other industry-specific custom product solutions.

About Good Meds

Founded in 2009, Good Meds medical cannabis dispensaries in Englewood and Lakewood, Colorado offer affordable access to premier cannabis for registered Colorado medical cannabis patients. The company’s carefully curated genetics are grown using the highest quality ingredients, to address a full spectrum of medical ailments. Good Meds generates revenue through its retail sales as well as wholesale products sold to non-Good Meds retail outlets in the recreational market. Good Meds supports the growth of the cannabis industry and abides by responsible business practices. The Good Meds assets were acquired by Andina Gold Corp. in 2019. For more information on Good Meds, please visit: https://www.goodmeds.com/.

About BOSM Labs

Serving the Colorado market since 2017, BOSM Labs balances science and art to produce quality-first, boutique extracts sold at both medical and recreational cannabis outlets. BOSM’s single-source concentrates begin with an artisan cultivation team and end with pronounced flavors that truly capture the essence of the flower at harvest. For more information on BOSM Labs, please visit: https://www.goodmeds.com/bosm-labs/.

Contact:
IR@americancannabisconsulting.com

303-974-4770

Investors@andinagold.com

303-222-8092

Forward-Looking Statements

This news release contains “forward-looking statements,” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”. These or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law

Cannabis and its derivatives are considered illegal “Schedule 1” drugs under the Controlled Substances Act (21 U.S.C. § 811). As such, Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. The criminal penalty structure in the Controlled Substances Act is determined based on the specific predicate violations, including but not limited to: simple possession, drug trafficking, attempt and conspiracy, distribution to minors, trafficking in drug paraphernalia, money laundering, racketeering, environmental damage from illegal manufacturing, continuing criminal enterprise, and smuggling. A first conviction under the Controlled Substances Act can generally result in possible fines from $250,000 to $50 million dollars, and incarceration for periods generally from five and up to forty years. For a second conviction, fines increase generally from $500,000 to $75 million dollars, and incarceration for periods generally from ten years to twenty years to life.

Primary Logo

Share

Share - Facebook


Share - Twitter

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Thu, 21 Jan 2021 16:50:01 +0000

 Trulieve Cannabis Corp. (TCNNF) Opens Location in Summerfield

 Trulieve Cannabis Corp. (TCNNF) Opens Location in Summerfield




 Trulieve Cannabis Corp. (TCNNF) Opens Location in Summerfield | Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™

























Published at Thu, 21 Jan 2021 15:28:05 +0000

2 Marijuana Stocks That May Surprise You In 2021

2 Marijuana Stocks That May Surprise You In 2021




2 Marijuana Stocks That May Surprise You In 2021 | Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™
























Published at Thu, 21 Jan 2021 17:21:51 +0000

Connecticut Governor Introduces Draft Bill to Legalize Adult-Use Cannabis

Connecticut Governor Introduces Draft Bill to Legalize Adult-Use Cannabis

When Mike Howard, director of cultivation at The Grove, first caught word of the record-breaking cannabis yields being harvested regularly by fellow grow teams around the country (Lume Cannabis in Michigan and Green Life Productions in Nevada) he knew the game was changing. Once Howard dug deeper into the news, he discovered a common catalyst behind the success of his peers: Both facilities were actively growing under the A3i LED grow light from Fohse. 

After hearing firsthand from the grow teams in Michigan and Nevada how they had increased yields over HPS by 31% and 100% respectively, Howard knew he had to get Fohse lighting into The Grove—and fast!

The Grove, a vertically integrated cannabis business with dispensary, cultivation, distribution and production licenses, has been producing, sourcing and selling high quality edibles, cartridges and recreational cannabis products since 2015. Their 26,600-square-foot growing and production facility is state-of-the-art and eco-friendly. They strive to recreate the conditions that cannabis would find in nature and use only all-natural growing media and inputs as well as biological measures to control any pests or diseases. It only makes sense then that they would seek out and select Fohse products—the best lighting fixtures in the business—to match The Grove’s exacting standards.

The dry Las Vegas air makes for a challenging indoor growing environment for cannabis. Fohse fixtures operate at much cooler temperatures than standard HPS fixtures.

At The Grove, this means that the humidifiers and cooling systems don’t have to work as hard, and that an equilibrium between temperature and humidity level can be more easily achieved and maintained. This has led to some of the record harvests being seen regularly at The Grove.

Looking at how Fohse’s A3i 1500-watt fixtures compare to standard 1000-watt DE HPS fixtures in an “apples to apples” comparison reveals just how in sync these intelligent fixtures are with cannabis. The numbers from a recent, late fall harvest tell an impressive tale:

 A3i 1500W LED1000W DE HPS
Total Fixtures3564
Total Plant Count520520
Grow MediaCoco potsCoco pots
Grow Area1056 sf1056 sf
Flower Cycle65 days65 days
PPFD (early flower)800-820800-820
PPFD (late flower)1250-13501000-1050
Wet weight1,392 lbs. (631.4 kg)716 lbs. (324.8 kg)
Dry Weight223 lbs. (101.3 kg)135 lbs. (61.2 k g)
Yield in oz./ Square Foot3.4 oz (96 g)2.05 oz (58 g)
Lbs. of Cannabis/Light Fixture*6.37 lbs. (2.98 kg)2.11 lbs. (.96 kg)
Total kWh41,07249,155

*Strawberry Cheesecake was the highest-yielding strain at 7.2 lbs/light, while Cookies was the lowest at 5.49 lbs/light

In the now-typical example above from the fall of 2020, the A3i system generated an average of 27% more light as compared to the HPS fixtures. This additional light led to an increase in dry yield harvest weights by a whopping 65%. All of this, while using 16% less energy than the HPS lighting it was compared to and in the same physical footprint of space with the same number of plants.

Remarkable results like those at The Grove are not a fluke or an accident and they are not restricted to Howard and his team alone. Growers all over are finding results like these to be the new norm, regardless of growing media and style of growing.

Lume Cannabis has been tracking results of their Fohse A3i fixtures for over 40 hydroponic growing cycles and across eight different strains of cannabis. Without fail, the team at Lume under Kevin Kuethe’s direction reports higher yields under the A3i than those grown under HPS. For example, with Fohse fixtures they have harvested 7,130 lbs. versus 5,241 lbs. with the same strains grown under HPS. THC levels under Fohse lights have been 3% higher too; 20% versus 17% on average. In other words, the cannabis that Lume grew under Fohse lighting netted more than $2.5 million more than the cannabis grown under HPS.

the grove led lighting cannabis

@Keene.Media

 

Steve Cantwell at Green Life Productions also reports unbelievable differences since switching over to Fohse’s A3i and F1V fixtures. Green Life Production’s typical harvests under their previous lighting system clocked in at 80-90 lbs. The average harvest now using Fohse fixtures is 160 to nearly 200 lbs. pulled from their 4×8, no-till, living organic soil beds.

Like Howard’s team at The Grove, Cantwell and his team have the enviable logistics problem of figuring out where to put all of the bounty from these sky-high yields. All three teams, The Grove (coco pots), Lume Cannabis (hydroponics) and Green Life Productions (live soil), are blowing harvest records out of the water time and time again across three drastically different cultivation styles. These highly regarded and experienced cannabis producers are showing that the rules have changed and that Fohse lighting fixtures enable previously unobtainable and unthinkable results.

Howard and the grow team at The Grove have achieved their amazing results by relying on the horticultural skills of their talented team, and also by utilizing two of Fohse’s premier products. They have predominantly been using the A3i model, Fohse’s workhorse grow light, to achieve their highest yields. The A3i is specifically designed to grow cannabis and that is exactly what it does. Its spectral distribution is custom-made to address the unique needs of cannabis. As evidenced in the remarkable yields outlined in the table above, the A3i’s output (of up to 4,970 µmol/s depending on configuration) can be adjusted to supply seasonably appropriate lighting depending on the growth phase of the crop. All of this while producing up to 156% more light per fixture and burning cooler (no hotter than dishwashing water) than traditional HPS grow lights. This means the A3i is safer to operate for both growers and their cannabis crops.

The A3i system is designed to handle the harsh extremes of a growing environment. The IP67-rated fixture will continue to operate at peak performance even with the moisture, dust, pests and biological debris, such as spores that are present in most indoor growing environments. Not many growers would expect their grow lights to still perform well after being submerged under several feet of water; the A3i can survive such a plunge and be relied on to deliver its photon payload as designed. Howard and his team at The Grove do not just rely on the A3i for their high yields. In their double-stack rooms they deploy Fohse’s lighter, more nimble F1V for its pound-for-pound power.

Just like the A3i, the F1V fixtures rely on industry-proven Samsung LEDs for their photon delivery. While almost the same dimensions as the A3i, at 38 lbs. (17.2 kg) per fixture they are almost half the weight of each A3i (70 lbs./31.75kg each). Like the A3i fixtures, their power supply rating is +100,000 hours. Depending on the needs of the grower and the ability of the existing systems, Fohse offers 420W, 600W, and 800W versions of the F1V. In his own F1V rooms, Howard has reported similarly positive results as in his A3i rooms: 60%+ yield increases, increased utility efficiencies, and better labor efficiency. The team now does not have to “chase canopy” by raising and lowering the lighting fixtures to achieve late-flower PPFD intensities like they did with the old LED lights that they were using in those double-tiered systems.

Fohse lighting products outperform their competition not only at The Grove, but anywhere they have been put to the test. So why hasn’t every cannabis grower switched over to Fohse?

Growers who have not yet seen the results firsthand still believe that LEDs cannot keep up with the high lighting demands of cannabis the way that HPS lighting traditionally has. The narrative had long been one of incremental change and an acceptance that two pounds of harvested yields per light fixture was the best one could expect. At the turn of the century, there was chatter that this didn’t have to be “good enough.”

the grove cannabis led lighting

@Keene.Media

 

By 2015, growers both professional and amateur alike had proven that three pounds per light was achievable based on advancements up to that point, but no one thought it would ever get better than that. Until Fohse set out to prove them all wrong, and then did. They showed that higher light output does not have to mean higher heat and that Diode technology had come a long way in just a few short years. Howard gives his take on this phenomenon:

“Everyone looks at LED lighting as still kind of a novelty; not something where it needs to be yet for cannabis growers. Having seen the evolution of LEDs that the Fohse team has created because of their cannabis mindset, it became obvious that we could focus on producing healthy plants.

A lot of other grow lighting companies are still looking at making and selling lights that can grow anything. Cannabis takes a lot of light and many companies and even growers don’t put enough light into commercial setups. Many cannabis growers never thought that LED technology was ever going to make it, but the power that comes out of Fohse fixtures is insane. Fohse lighting lets the grower focus on plant health and our yields show that. With Fohse LEDs overtaking HPS, you can really push the limits of your grow.”

As Howard said, Fohse fixtures are engineered with a “cannabis mindset.” HPS light output has plateaued because the added heat load is both detrimental to the cannabis crop and uneconomical to counterbalance. With Fohse fixtures growers can focus more on the nuances of a high-intensity light environment instead of combatting heat. Ever since that first time Mike Howard oversaw production in the initial grow room where Fohse products were installed at the Grove, he immediately saw the results. He is now vowing to keep replacing The Grove’s less efficient HPS fixtures and outdated LEDs with Fohse lighting as they continue expanding. Find out how switching to Fohse fixtures will increase your cannabis production and about all of Fohse’s record-busting lighting at Fohse.com.

Published at Thu, 21 Jan 2021 16:22:00 +0000

Harvest at The Grove: How Fohse LED Fixtures Increased Yields and Drove Higher ROI

Harvest at The Grove: How Fohse LED Fixtures Increased Yields and Drove Higher ROI

When Mike Howard, director of cultivation at The Grove, first caught word of the record-breaking cannabis yields being harvested regularly by fellow grow teams around the country (Lume Cannabis in Michigan and Green Life Productions in Nevada) he knew the game was changing. Once Howard dug deeper into the news, he discovered a common catalyst behind the success of his peers: Both facilities were actively growing under the A3i LED grow light from Fohse. 

After hearing firsthand from the grow teams in Michigan and Nevada how they had increased yields over HPS by 31% and 100% respectively, Howard knew he had to get Fohse lighting into The Grove—and fast!

The Grove, a vertically integrated cannabis business with dispensary, cultivation, distribution and production licenses, has been producing, sourcing and selling high quality edibles, cartridges and recreational cannabis products since 2015. Their 26,600-square-foot growing and production facility is state-of-the-art and eco-friendly. They strive to recreate the conditions that cannabis would find in nature and use only all-natural growing media and inputs as well as biological measures to control any pests or diseases. It only makes sense then that they would seek out and select Fohse products—the best lighting fixtures in the business—to match The Grove’s exacting standards.

The dry Las Vegas air makes for a challenging indoor growing environment for cannabis. Fohse fixtures operate at much cooler temperatures than standard HPS fixtures.

At The Grove, this means that the humidifiers and cooling systems don’t have to work as hard, and that an equilibrium between temperature and humidity level can be more easily achieved and maintained. This has led to some of the record harvests being seen regularly at The Grove.

Looking at how Fohse’s A3i 1500-watt fixtures compare to standard 1000-watt DE HPS fixtures in an “apples to apples” comparison reveals just how in sync these intelligent fixtures are with cannabis. The numbers from a recent, late fall harvest tell an impressive tale:

 A3i 1500W LED1000W DE HPS
Total Fixtures3564
Total Plant Count520520
Grow MediaCoco potsCoco pots
Grow Area1056 sf1056 sf
Flower Cycle65 days65 days
PPFD (early flower)800-820800-820
PPFD (late flower)1250-13501000-1050
Wet weight1,392 lbs. (631.4 kg)716 lbs. (324.8 kg)
Dry Weight223 lbs. (101.3 kg)135 lbs. (61.2 k g)
Yield in oz./ Square Foot3.4 oz (96 g)2.05 oz (58 g)
Lbs. of Cannabis/Light Fixture*6.37 lbs. (2.98 kg)2.11 lbs. (.96 kg)
Total kWh41,07249,155

*Strawberry Cheesecake was the highest-yielding strain at 7.2 lbs/light, while Cookies was the lowest at 5.49 lbs/light

In the now-typical example above from the fall of 2020, the A3i system generated an average of 27% more light as compared to the HPS fixtures. This additional light led to an increase in dry yield harvest weights by a whopping 65%. All of this, while using 16% less energy than the HPS lighting it was compared to and in the same physical footprint of space with the same number of plants.

Remarkable results like those at The Grove are not a fluke or an accident and they are not restricted to Howard and his team alone. Growers all over are finding results like these to be the new norm, regardless of growing media and style of growing.

Lume Cannabis has been tracking results of their Fohse A3i fixtures for over 40 hydroponic growing cycles and across eight different strains of cannabis. Without fail, the team at Lume under Kevin Kuethe’s direction reports higher yields under the A3i than those grown under HPS. For example, with Fohse fixtures they have harvested 7,130 lbs. versus 5,241 lbs. with the same strains grown under HPS. THC levels under Fohse lights have been 3% higher too; 20% versus 17% on average. In other words, the cannabis that Lume grew under Fohse lighting netted more than $2.5 million more than the cannabis grown under HPS.

the grove led lighting cannabis

@Keene.Media

 

Steve Cantwell at Green Life Productions also reports unbelievable differences since switching over to Fohse’s A3i and F1V fixtures. Green Life Production’s typical harvests under their previous lighting system clocked in at 80-90 lbs. The average harvest now using Fohse fixtures is 160 to nearly 200 lbs. pulled from their 4×8, no-till, living organic soil beds.

Like Howard’s team at The Grove, Cantwell and his team have the enviable logistics problem of figuring out where to put all of the bounty from these sky-high yields. All three teams, The Grove (coco pots), Lume Cannabis (hydroponics) and Green Life Productions (live soil), are blowing harvest records out of the water time and time again across three drastically different cultivation styles. These highly regarded and experienced cannabis producers are showing that the rules have changed and that Fohse lighting fixtures enable previously unobtainable and unthinkable results.

Howard and the grow team at The Grove have achieved their amazing results by relying on the horticultural skills of their talented team, and also by utilizing two of Fohse’s premier products. They have predominantly been using the A3i model, Fohse’s workhorse grow light, to achieve their highest yields. The A3i is specifically designed to grow cannabis and that is exactly what it does. Its spectral distribution is custom-made to address the unique needs of cannabis. As evidenced in the remarkable yields outlined in the table above, the A3i’s output (of up to 4,970 µmol/s depending on configuration) can be adjusted to supply seasonably appropriate lighting depending on the growth phase of the crop. All of this while producing up to 156% more light per fixture and burning cooler (no hotter than dishwashing water) than traditional HPS grow lights. This means the A3i is safer to operate for both growers and their cannabis crops.

The A3i system is designed to handle the harsh extremes of a growing environment. The IP67-rated fixture will continue to operate at peak performance even with the moisture, dust, pests and biological debris, such as spores that are present in most indoor growing environments. Not many growers would expect their grow lights to still perform well after being submerged under several feet of water; the A3i can survive such a plunge and be relied on to deliver its photon payload as designed. Howard and his team at The Grove do not just rely on the A3i for their high yields. In their double-stack rooms they deploy Fohse’s lighter, more nimble F1V for its pound-for-pound power.

Just like the A3i, the F1V fixtures rely on industry-proven Samsung LEDs for their photon delivery. While almost the same dimensions as the A3i, at 38 lbs. (17.2 kg) per fixture they are almost half the weight of each A3i (70 lbs./31.75kg each). Like the A3i fixtures, their power supply rating is +100,000 hours. Depending on the needs of the grower and the ability of the existing systems, Fohse offers 420W, 600W, and 800W versions of the F1V. In his own F1V rooms, Howard has reported similarly positive results as in his A3i rooms: 60%+ yield increases, increased utility efficiencies, and better labor efficiency. The team now does not have to “chase canopy” by raising and lowering the lighting fixtures to achieve late-flower PPFD intensities like they did with the old LED lights that they were using in those double-tiered systems.

Fohse lighting products outperform their competition not only at The Grove, but anywhere they have been put to the test. So why hasn’t every cannabis grower switched over to Fohse?

Growers who have not yet seen the results firsthand still believe that LEDs cannot keep up with the high lighting demands of cannabis the way that HPS lighting traditionally has. The narrative had long been one of incremental change and an acceptance that two pounds of harvested yields per light fixture was the best one could expect. At the turn of the century, there was chatter that this didn’t have to be “good enough.”

the grove cannabis led lighting

@Keene.Media

 

By 2015, growers both professional and amateur alike had proven that three pounds per light was achievable based on advancements up to that point, but no one thought it would ever get better than that. Until Fohse set out to prove them all wrong, and then did. They showed that higher light output does not have to mean higher heat and that Diode technology had come a long way in just a few short years. Howard gives his take on this phenomenon:

“Everyone looks at LED lighting as still kind of a novelty; not something where it needs to be yet for cannabis growers. Having seen the evolution of LEDs that the Fohse team has created because of their cannabis mindset, it became obvious that we could focus on producing healthy plants.

A lot of other grow lighting companies are still looking at making and selling lights that can grow anything. Cannabis takes a lot of light and many companies and even growers don’t put enough light into commercial setups. Many cannabis growers never thought that LED technology was ever going to make it, but the power that comes out of Fohse fixtures is insane. Fohse lighting lets the grower focus on plant health and our yields show that. With Fohse LEDs overtaking HPS, you can really push the limits of your grow.”

As Howard said, Fohse fixtures are engineered with a “cannabis mindset.” HPS light output has plateaued because the added heat load is both detrimental to the cannabis crop and uneconomical to counterbalance. With Fohse fixtures growers can focus more on the nuances of a high-intensity light environment instead of combatting heat. Ever since that first time Mike Howard oversaw production in the initial grow room where Fohse products were installed at the Grove, he immediately saw the results. He is now vowing to keep replacing The Grove’s less efficient HPS fixtures and outdated LEDs with Fohse lighting as they continue expanding. Find out how switching to Fohse fixtures will increase your cannabis production and about all of Fohse’s record-busting lighting at Fohse.com.

Published at Wed, 20 Jan 2021 19:47:00 +0000